Interferon-α and angiogenic dysregulation in pregnant lupus patients destined for preeclampsia

Objective. To investigate whether an elevatedinterferon-␣(IFN␣) level early in pregnancy is associ-ated with poor pregnancy outcomes and to examine the relationship of an elevated IFN␣level to angiogenicimbalance.Methods. Women were enrolled in a longitudinalcase–control study of pregnant patients w...

Full description

Autores:
Andrade, Danieli
Kim, Mimi
Blanco, Luz
Karumanchi, Ananth
Koo, Gloria
Redecha, Patricia
Kirou, Kyriakos
Álvarez Gómez, Ángela María
Mulla, Melissa
Crow, Mary K.
Abrahams, Vikki M.
Kaplan, Mariana J.
Salmon, Jane E.
Tipo de recurso:
Article of investigation
Fecha de publicación:
2015
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/25906
Acceso en línea:
http://hdl.handle.net/10495/25906
Palabra clave:
Lupus Vulgar
Lupus Vulgaris
Preeclampsia
Pre-Eclampsia
Lupus Eritematoso Cutáneo
Lupus Erythematosus, Cutaneous
Mujeres Embarazadas
Pregnant Women
Interferón-alfa
Interferon-alpha
Rights
openAccess
License
http://creativecommons.org/licenses/by-nc-nd/2.5/co/
id UDEA2_9804eee6eb953d1950d297b360ec3020
oai_identifier_str oai:bibliotecadigital.udea.edu.co:10495/25906
network_acronym_str UDEA2
network_name_str Repositorio UdeA
repository_id_str
dc.title.spa.fl_str_mv Interferon-α and angiogenic dysregulation in pregnant lupus patients destined for preeclampsia
title Interferon-α and angiogenic dysregulation in pregnant lupus patients destined for preeclampsia
spellingShingle Interferon-α and angiogenic dysregulation in pregnant lupus patients destined for preeclampsia
Lupus Vulgar
Lupus Vulgaris
Preeclampsia
Pre-Eclampsia
Lupus Eritematoso Cutáneo
Lupus Erythematosus, Cutaneous
Mujeres Embarazadas
Pregnant Women
Interferón-alfa
Interferon-alpha
title_short Interferon-α and angiogenic dysregulation in pregnant lupus patients destined for preeclampsia
title_full Interferon-α and angiogenic dysregulation in pregnant lupus patients destined for preeclampsia
title_fullStr Interferon-α and angiogenic dysregulation in pregnant lupus patients destined for preeclampsia
title_full_unstemmed Interferon-α and angiogenic dysregulation in pregnant lupus patients destined for preeclampsia
title_sort Interferon-α and angiogenic dysregulation in pregnant lupus patients destined for preeclampsia
dc.creator.fl_str_mv Andrade, Danieli
Kim, Mimi
Blanco, Luz
Karumanchi, Ananth
Koo, Gloria
Redecha, Patricia
Kirou, Kyriakos
Álvarez Gómez, Ángela María
Mulla, Melissa
Crow, Mary K.
Abrahams, Vikki M.
Kaplan, Mariana J.
Salmon, Jane E.
dc.contributor.author.none.fl_str_mv Andrade, Danieli
Kim, Mimi
Blanco, Luz
Karumanchi, Ananth
Koo, Gloria
Redecha, Patricia
Kirou, Kyriakos
Álvarez Gómez, Ángela María
Mulla, Melissa
Crow, Mary K.
Abrahams, Vikki M.
Kaplan, Mariana J.
Salmon, Jane E.
dc.subject.decs.none.fl_str_mv Lupus Vulgar
Lupus Vulgaris
Preeclampsia
Pre-Eclampsia
Lupus Eritematoso Cutáneo
Lupus Erythematosus, Cutaneous
Mujeres Embarazadas
Pregnant Women
Interferón-alfa
Interferon-alpha
topic Lupus Vulgar
Lupus Vulgaris
Preeclampsia
Pre-Eclampsia
Lupus Eritematoso Cutáneo
Lupus Erythematosus, Cutaneous
Mujeres Embarazadas
Pregnant Women
Interferón-alfa
Interferon-alpha
description Objective. To investigate whether an elevatedinterferon-␣(IFN␣) level early in pregnancy is associ-ated with poor pregnancy outcomes and to examine the relationship of an elevated IFN␣level to angiogenicimbalance.Methods. Women were enrolled in a longitudinalcase–control study of pregnant patients with lupus.Serum samples obtained monthly throughout preg-nancy were assayed for IFN␣and for the antiangiogenicfactor soluble Flt-1 and the proangiogenic factor pla-centa growth factor (PlGF). Each of 28 patients withsystemic lupus erythematosus (SLE) with a poor preg-nancy outcome was matched to an SLE patient with anuncomplicated pregnancy and to a pregnant healthycontrol. The effects of IFN␣and/or soluble Flt-1 onhuman endothelial cells and endothelial cell–trophoblast interactions were assessed.Results. Compared to SLE patients with uncom-plicated pregnancies, patients with preeclampsia hadincreased IFN␣levels before clinical symptoms. Pa-tients without autoimmune disease who developed pre-eclampsia did not have increased IFN␣levels. In SLEpatients with low IFN␣levels, marked angiogenic im-balance (higher soluble Flt-1, lower PlGF, and highersoluble Flt-1:PlGF ratios) preceded maternal manifes-tations of preeclampsia, whereas in SLE patients withhigh IFN␣levels, preeclampsia occurred without evi-dence of systemic angiogenic imbalance. Treatment ofhuman endothelial cells with soluble Flt-1 inducedexpression of sFLT1 messenger RNA, and IFN␣dra-matically amplified responses to soluble Flt-1. In amodel of spiral artery transformation, only the combi-nation of IFN␣and soluble Flt-1 disrupted the ability oftrophoblast cells to remodel endothelial tube structures.Conclusion. Our findings identify a new mecha-nism by which IFN␣induces an antiangiogenic milieuand increases the sensitivity of endothelial cells tosoluble Flt-1, and suggest that elevated IFN␣levels maycontribute to the pathogenesis of preeclampsia in somepregnant patients with SLE
publishDate 2015
dc.date.issued.none.fl_str_mv 2015
dc.date.accessioned.none.fl_str_mv 2022-02-09T14:22:18Z
dc.date.available.none.fl_str_mv 2022-02-09T14:22:18Z
dc.type.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.hasversion.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.redcol.spa.fl_str_mv https://purl.org/redcol/resource_type/ART
dc.type.local.spa.fl_str_mv Artículo de investigación
format http://purl.org/coar/resource_type/c_2df8fbb1
status_str publishedVersion
dc.identifier.issn.none.fl_str_mv 0004-3591
dc.identifier.uri.none.fl_str_mv http://hdl.handle.net/10495/25906
dc.identifier.doi.none.fl_str_mv 10.1002/art.39029
dc.identifier.eissn.none.fl_str_mv 1529-0131
identifier_str_mv 0004-3591
10.1002/art.39029
1529-0131
url http://hdl.handle.net/10495/25906
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.ispartofjournalabbrev.spa.fl_str_mv Arthritis Rheum.
dc.rights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.rights.accessrights.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.creativecommons.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.format.extent.spa.fl_str_mv 11
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv American College of Rheumatology
dc.publisher.group.spa.fl_str_mv Grupo Reproducción
dc.publisher.place.spa.fl_str_mv Atlanta, Estados Unidos
institution Universidad de Antioquia
bitstream.url.fl_str_mv https://bibliotecadigital.udea.edu.co/bitstream/10495/25906/1/AlvarezAngela_2015_InterferonalphaAngiogenicDysregulationinPregnant.pdf
https://bibliotecadigital.udea.edu.co/bitstream/10495/25906/2/license_rdf
https://bibliotecadigital.udea.edu.co/bitstream/10495/25906/3/license.txt
bitstream.checksum.fl_str_mv 3e695edd19de4c2d5fd82b1c26ac83c2
b88b088d9957e670ce3b3fbe2eedbc13
8a4605be74aa9ea9d79846c1fba20a33
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional Universidad de Antioquia
repository.mail.fl_str_mv andres.perez@udea.edu.co
_version_ 1812173304585256960
spelling Andrade, DanieliKim, MimiBlanco, LuzKarumanchi, AnanthKoo, GloriaRedecha, PatriciaKirou, KyriakosÁlvarez Gómez, Ángela MaríaMulla, MelissaCrow, Mary K.Abrahams, Vikki M.Kaplan, Mariana J.Salmon, Jane E.2022-02-09T14:22:18Z2022-02-09T14:22:18Z20150004-3591http://hdl.handle.net/10495/2590610.1002/art.390291529-0131Objective. To investigate whether an elevatedinterferon-␣(IFN␣) level early in pregnancy is associ-ated with poor pregnancy outcomes and to examine the relationship of an elevated IFN␣level to angiogenicimbalance.Methods. Women were enrolled in a longitudinalcase–control study of pregnant patients with lupus.Serum samples obtained monthly throughout preg-nancy were assayed for IFN␣and for the antiangiogenicfactor soluble Flt-1 and the proangiogenic factor pla-centa growth factor (PlGF). Each of 28 patients withsystemic lupus erythematosus (SLE) with a poor preg-nancy outcome was matched to an SLE patient with anuncomplicated pregnancy and to a pregnant healthycontrol. The effects of IFN␣and/or soluble Flt-1 onhuman endothelial cells and endothelial cell–trophoblast interactions were assessed.Results. Compared to SLE patients with uncom-plicated pregnancies, patients with preeclampsia hadincreased IFN␣levels before clinical symptoms. Pa-tients without autoimmune disease who developed pre-eclampsia did not have increased IFN␣levels. In SLEpatients with low IFN␣levels, marked angiogenic im-balance (higher soluble Flt-1, lower PlGF, and highersoluble Flt-1:PlGF ratios) preceded maternal manifes-tations of preeclampsia, whereas in SLE patients withhigh IFN␣levels, preeclampsia occurred without evi-dence of systemic angiogenic imbalance. Treatment ofhuman endothelial cells with soluble Flt-1 inducedexpression of sFLT1 messenger RNA, and IFN␣dra-matically amplified responses to soluble Flt-1. In amodel of spiral artery transformation, only the combi-nation of IFN␣and soluble Flt-1 disrupted the ability oftrophoblast cells to remodel endothelial tube structures.Conclusion. Our findings identify a new mecha-nism by which IFN␣induces an antiangiogenic milieuand increases the sensitivity of endothelial cells tosoluble Flt-1, and suggest that elevated IFN␣levels maycontribute to the pathogenesis of preeclampsia in somepregnant patients with SLECOL000096211application/pdfengAmerican College of RheumatologyGrupo ReproducciónAtlanta, Estados Unidosinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARTArtículo de investigaciónhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc-nd/2.5/co/http://purl.org/coar/access_right/c_abf2https://creativecommons.org/licenses/by-nc-nd/4.0/Interferon-α and angiogenic dysregulation in pregnant lupus patients destined for preeclampsiaLupus VulgarLupus VulgarisPreeclampsiaPre-EclampsiaLupus Eritematoso CutáneoLupus Erythematosus, CutaneousMujeres EmbarazadasPregnant WomenInterferón-alfaInterferon-alphaArthritis Rheum.Arthritis & Rheumatism977987674ORIGINALAlvarezAngela_2015_InterferonalphaAngiogenicDysregulationinPregnant.pdfAlvarezAngela_2015_InterferonalphaAngiogenicDysregulationinPregnant.pdfArtículo de investigaciónapplication/pdf444259https://bibliotecadigital.udea.edu.co/bitstream/10495/25906/1/AlvarezAngela_2015_InterferonalphaAngiogenicDysregulationinPregnant.pdf3e695edd19de4c2d5fd82b1c26ac83c2MD51CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8823https://bibliotecadigital.udea.edu.co/bitstream/10495/25906/2/license_rdfb88b088d9957e670ce3b3fbe2eedbc13MD52LICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://bibliotecadigital.udea.edu.co/bitstream/10495/25906/3/license.txt8a4605be74aa9ea9d79846c1fba20a33MD5310495/25906oai:bibliotecadigital.udea.edu.co:10495/259062022-10-29 10:24:53.669Repositorio Institucional Universidad de Antioquiaandres.perez@udea.edu.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